New strategies in vaccine delivery

S.T.P. Pharma Sciences

Volumn 10, Issue 4, 2000, Pages 269-278

  Alpar, H O ^a   Ward, K R ^a   Williamson, E D ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Microparticles Novel technologies; Mucosal; Non parenteral; Single dose vaccines

Indexed keywords

POLYMER; VACCINE;

ANIMAL EXPERIMENT; DRUG DELIVERY SYSTEM; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; REVIEW; UNITED KINGDOM; VACCINATION;

EID: 0033849463     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccines
2. Genetic vaccines
3. Controlled release vaccines - Biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles
4. Single-administration vaccines: Controlled release technology to mimic repeated immunizations
5. New advances in microsphere-based single-dose vaccines
6. Microencapsulation of antigens using biodegradable polyesters: Facts and phantasies
7. Controlled release of bioactive agents from lactide/glycolide polymers
8. Immunopotentiation and delivery systems for antigens for single-step immunization: Recent trends and progress
9. Development of a single-shot subunit vaccine for HIV-1. Part 2. Defining optimal autoboost characteristics to maximise the humoral immune response
10. Biodegradable microparticles with different relesae profiles: Effect on the immuneresponse following a single administration via intranasal and intramuscular routes
11. Oral and nasal immunization with microencapsulated clinically relevant proteins
12. Design and delivery of non-parenteral vaccines
13. Characteristics of capillary permeability in nasal mucosa
14. Antigen sampling across epithelial barriers and induction of mucosal immune responses
15. Intranasal administration of poly(lactic acid) microsphere coencapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse
16. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits
17. Identification of some of the physicochemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery
18. Chitosan microspheres for nasal delivery of the model antigen bovine serum albumin
19. Biodegradable nanoparticles in nasal vaccine delivery: Effect of particle size and loading
20. Enhanced immune response to single dose injections using simple admixtures of microsphere-encapsulated antigen with chitosans
21. Regulation of cytokine expression by adjuvants in vivo
22. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases
23. Maintaining and enhancing vaccine immunogenicity
24. A morphologic study of rabbit bronchial lymphoid aggregates and lymphoepithelium, Laboratory Investigation
25. The nature of immunity at mucosal surfaces - A brief review
26. Mucosal immunity: Implications for vaccine development
27. The membranes epithelial (M) cells and mucosal immune system
28. Porosity of the basement membrane overlying Peyer's patches in rats and monkeys
29. Biodegradable microspheres: Vaccine delivery systems for oral immunization
30. Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability
31. Persorption of particles: Physiology and pharmacology
32. A study of particulate intestinal absorption and hepatocellular uptake
33. Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
34. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles
35. Uptake and translocation of microparticles in small intestine. Morphology and quantitation of particle distribution
36. Accumulation of 2 μm latex particles in mouse Peyer's patches during chronic latex feeding
37. The mucosal immune system: From fundamental concepts to vaccine development
38. New advances in vaccine delivery systems
39. Oral vaccine models: Multiple delivery systems employing tetanus toxoid
40. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection
41. Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(dl-lactide-co-glycolide) microspheres
42. The potential of liposomes in oral drug delivery
43. In vitro evaluation of polymerized liposomes as an oral drug delivery system
44. Cellular and humoral responses to microencapsulated Yersinia pestis vaccines following oral delivery
45. Genetic vaccines: Strategies for optimization
46. Immunological responses following oral and intranasal administration of PLA microspheres manufactured using surfactants with adjuvant properties
47. Enhancement of immune response to plasmid DNA by encapsulation in poly(lactic acid) microspheres and coencapsulation of antigen
48. The birth of new delivery systems
49. Ligand-targeted liposomes